trending Market Intelligence /marketintelligence/en/news-insights/trending/uhoAd34OCvT77yQJfhTi0w2 content esgSubNav
In This List

Indian high court grants Reckitt Benckiser rights to advertise Ayurvedic drugs

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

S&P Capital IQ Pro | Powered by Expert Insights

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud


Indian high court grants Reckitt Benckiser rights to advertise Ayurvedic drugs

The Delhi High Court has ordered an Indian government body not to take coercive actions against consumer goods giant Reckitt Benckiser Group PLC if it advertises its Ayurvedic, Siddha and Unani range of medicines, The Economic Times (India) reported Jan. 15, citing a court filing.

The ruling follows an appeal by the Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy, to prohibit the U.K.-based company from selling its range of drugs under the country's drugs and cosmetics laws, according to the report.

Reckitt Benckiser argued in court that the company has a manufacturing license to sell its range of products, which include Strepsils, Moov, Krack cream and Dermicool talcum powder, the report said.